Held on November 8th and 9th, in São Paulo (SP), the event brought together investors, entrepreneurs, industry representatives, scientists, researchers and universities with the aim of promoting connections, discussions and boosting technology development. The festival was organized by Emerge, a company specialized in guiding technological innovations to the market.
Recognition for scientific performance
Participation in the Deep Tech Summit represents recognition of Celluris’ scientific performance in the process of revolution and innovation in the treatment of hematological and solid tumors around the world. On that occasion, it was possible to understand more about the innovation ecosystem of Brazilian Deep Techs and articulate strategic partnerships to boost research into CAR-T technology.
Innovative company
Celluris is a pioneer in Latin America in the development of personalized treatments for cancer patients using CAR-T technology for solid tumors. This innovative technique consists of modifying the patient’s own cells, allowing them to recognize the tumor as a target and combat it precisely.
CAR-T Cell treatment has emerged as a promising technological and scientific alternative to conventional therapies, providing an improvement in the physical well-being of patients and, above all, important chances of a cure.
To find out more about this innovative solution and Celluris’ scientific activities, visit the website.
